<DOC>
	<DOCNO>NCT02664909</DOCNO>
	<brief_summary>This study double-blinded placebo-controlled clinical trial evaluate efficacy 1 gram topically apply tranexamic acid vs. saline placebo reduction transfusion follow hip hemiarthroplasty surgery .</brief_summary>
	<brief_title>Topical ( Intra-Articular ) Tranexamic Acid Transfusion Rates Following Hip Hemiarthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Femoral Neck Fractures</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients undergo hip hemiarthroplasty surgery displace femoral neck fracture History hemophilia , history deep vein thrombosis , history pulmonary embolism , history thrombophilia , history chronic renal failure Patients coronary ischemia ( active within past calendar year ) , patient suffer myocardial infarction , undergone percutaneous coronary intervention , undergone coronary artery bypass grafting , undergone revascularization procedure within past calendar year Patients active subarachnoid hemorrhage , acquire defective color vision , patient sustain pathologic fracture ( fracture neoplastic lesion ) , patient pregnant Patients know allergy tranexamic acid Patients take Warfarin , Dabigatran , Rivaroxaban , Apixaban , Fresh Frozen Plasma</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hip Hemiarthroplasty</keyword>
	<keyword>Tranexamic Acid</keyword>
	<keyword>Topical</keyword>
	<keyword>Blood Transfusion</keyword>
</DOC>